Results 211 to 220 of about 85,877 (261)

The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia. [PDF]

PLoS One
Mariana N, Gayatri A, Widyahening IS, Bela B, Soedarsono S, Maemunah I, Rosamarlina R, Setiawaty V, Myneedu VP, Nelwan EJ, Ascobat P.   +10 more
europepmc   +1 more source

Risk factors for treatment failure in multidrug resistant tuberculosis in Tunisia: An analytic study

F. Tritar, Soumaya Ben Saad, M. Ferchichi, A. Ben Mansour, A. Slim, O. Neffati, Hedia Bellili, L. Slim, H. Daghfous   +8 more
openalex   +2 more sources

Epidemiologic trajectories and burden of multidrug-resistant tuberculosis (MDR-TB) mortality across South Asia: An analysis of Global Burden of Disease data (1990-2023) with machine learning forecasting to 2050. [PDF]

J Clin Tuberc Other Mycobact Dis
Khalil I, Abrar S, Khalid Reza IM, Hossain MI, Akter MM, Sultana F.   +5 more
europepmc   +1 more source

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. [PDF]

Emerg Infect Dis
Gerussi V, Petersen T, Bonnet I, Aubry A, Bachir M, Gyde E, Morel F, Poignon C, Rached B, Pourcher V, Rioux C, Vallois D, Veziris N, Robert J, Guglielmetti L.   +14 more
europepmc   +1 more source

Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China. [PDF]

BMC Infect Dis
Wang J, Dong J, Chen Z, Xu Y, Qiu W, Chen S, Pei H, Zhong Y.   +7 more
europepmc   +1 more source

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis. [PDF]

Pathogens
Bogiel T, Dolska E, Zimna M, Nakonowska K, Krawiecka D, Żebracka R, Pochowski M, Krawczyk A.   +7 more
europepmc   +1 more source

Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?

Dharmendra Singh, Bidisa Sarkar, Saurabh Yadav, Kamalesh Sarkar   +3 more
openalex   +1 more source

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial. [PDF]

Contemp Clin Trials
Kendall MA, Hughes MD, Kim S, Aaron LA, Naini L, Suryavanshi N, Shah NS, Rouzier V, Hafkin J, Sise T, Beck J, Heckman BE, Haberer JE, Harrington M, Scarsi KK, Hesseling AC, Swindells S, Churchyard GJ, Gupta A.   +18 more
europepmc   +1 more source

Time to sputum culture conversion and associated factors in multidrug-resistant tuberculosis patients in Southwestern Oromia, Ethiopia: a ten-year retrospective follow-up study. [PDF]

BMC Pulm Med
Balay G, Bonsa Z, Bekele E, Abeba G, Solomon E, Tadesse M, Kebede W, Abebe G.   +7 more
europepmc   +1 more source